Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed [Phase 3]

View source ↗

Summary

Phase 3 trial update for Beijing Institute of Biological Products' Diphtheria, Tetanus and Acellular Pertussis vaccine adsorbed; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Three Components) (Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed)

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Whooping Cough, Diphtheria | Phase 3 | Status: ACTIVE_NOT_RECRUITING